Status:
ACTIVE_NOT_RECRUITING
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
Lead Sponsor:
Ohio State University
Conditions:
Dyspnea
Eligibility:
All Genders
18-110 years
Phase:
NA
Brief Summary
The BREATHE-easy is a randomized control trial assessing the efficacy of the novel PneumoCool device to alleviate subjective shortness of breath. The PneumoCool device is a disposable, bladeless, high...
Detailed Description
This will be randomized control trial (RCT) for patients admitted to the Ohio State University Wexner Medical Center, ROSS and James Cancer Hospital. Patients will be screened to assess eligibility. T...
Eligibility Criteria
Inclusion
- Dyspnea (Borg Scale \> 3)
- Admitted to University hospital, ROSS or James Cancer Hospital with expected length of stay \> 24 hours
- Age 18 years or more
Exclusion
- Delirium (assessed by CAMICU) or dementia or brain injury precluding ability to consent and or respond to outcome scales
- Prisoner status
- Continuous mechanical ventilation
- Patients with motor disability with inability to maneuver the device
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05416437
Start Date
June 15 2022
End Date
June 30 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210